Is Metastatic Prostate Cancer Tailor-Made for Precision Oncology? (Fred Hutchinson Cancer Research Center)

Metastatic prostate cancer presents an appealing target for precision oncology, according to new work from scientists at Fred Hutchinson Cancer Research Center and the University of Washington. In a study published Monday in the journal Nature Medicine, the researchers showed that though metastases from different patients varied widely in their genetic characteristics, metastases within a single patient were remarkably similar. These results suggest not merely that patients with metastatic prost...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news